Search Results - "Link, MP"

Treatment of Children and Young Adults with Early-Stage Non-Hodgkin's Lymphoma by Link, Michael P, Shuster, Jonathan J, Donaldson, Sarah S, Berard, Costan W, Murphy, Sharon B

“…The improvement over the past two decades in the outcome for children and young adults with non-Hodgkin's lymphoma is one of the success stories of pediatric…”
Get full text

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone by Grier, Holcombe E, Krailo, Mark D, Tarbell, Nancy J, Link, Michael P, Fryer, Christopher J.H, Pritchard, Douglas J, Gebhardt, Mark C, Dickman, Paul S, Perlman, Elizabeth J, Meyers, Paul A, Donaldson, Sarah S, Moore, Sheila, Rausen, Aaron R, Vietti, Teresa J, Miser, James S

“…Ewing's sarcoma, a highly malignant tumor of children, adolescents, and young adults, often responds to local excision plus a now-standard four-drug regimen of…”
Get full text

Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651 by GOORIN, Allen M, SCHWARTZENTRUBER, Douglas J, DEVIDAS, Meenakshi, GEBHARDT, Mark C, AYALA, Alberto G, HARRIS, Michael B, HELMAN, Lee J, GRIER, Holcombe E, LINK, Michael P

“…Successful therapeutic interventions to prevent disease progression in patients with nonmetastatic osteosarcoma have included surgery with adjuvant…”
Get full text

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV by BRENEMAN, John C, LYDEN, Elizabeth, MEYER, William H, BAKER, K. Scott, PAIDAS, Charles N, CRIST, William M, PAPPO, Alberto S, LINK, Michael P, ANDERSON, James R, PARHAM, David M, QUALMAN, Stephen J, WHARAM, Moody D, DONALDSON, Sarah S, MAURER, Harold M

“…To identify risk factors associated with outcomes in children with metastatic rhabdomyosarcoma (RMS) treated on the fourth Intergroup Rhabdomyosarcoma Study…”
Get full text

Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457—A Report From the Children's Oncology Group by BERNSTEIN, Mark L, DEVIDAS, Meenakshi, WAINER, Irving W, DICKMAN, Paul S, LINK, Michael P, GOORIN, Alien, GRIER, Holcombe E, LAFRENIERE, Dominique, SOUID, Abdul-Kader, MEYERS, Paul A, GEBHARDT, Mark, STINE, Kimo, NICHOLAS, Richard, PERLMAN, Elizabeth J, DUBOWY, Ronald

“…Prognosis is poor for Ewing sarcoma patients with metastasis at diagnosis. We intensified a five-drug therapy (ifosfamide, etoposide alternated with…”
Get full text

Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study by MISER, James S, KRAILO, Mark D, DONALDSON, Sarah S, MOORE, Sheila, RAUSEN, Aaron R, VIETTI, Teresa J, GRIER, Holcolmbe E, TARBELL, Nancy J, LINK, Michael P, FRYER, Christopher J. H, PRITCHARD, Douglas J, GEBHARDT, Mark C, DICKMAN, Paul S, PERLMAN, Elizabeth J, MEYERS, Paul A

“…One hundred twenty patients with metastatic Ewing's sarcoma or primitive neuroectodermal tumor (PNET) of bone were entered onto a randomized trial evaluating…”
Get full text

High‐dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma by Crews, Kristine R., Liu, Tiebin, Rodriguez‐Galindo, Carlos, Tan, Ming, Meyer, William H., Panetta, J. Carl, Link, Michael P., Daw, Najat C.

“…BACKGROUND High‐dose methotrexate (HDMTX) is used frequently in combination regimens that include nephrotoxic chemotherapy. The authors evaluated the impact of…”
Get full text

High Incidence of Potential p53 Inactivation in Poor Outcome Childhood Acute Lymphoblastic Leukemia at Diagnosis by Marks, David I., Kurz, Benedikt W., Link, Michael P., Ng, Eliza, Shuster, Jonathan J., Lauer, Stephen J., Brodsky, Isadore, Haines, Dale S.

“…Previous studies have indicated that p53 gene mutations were an uncommon event in acute lymphoblastic leukemia (ALL) in children. In one series of 330…”
Get full text

Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey by HILDEN, Joanne M, EMANUEL, Ezekiel J, FAIRCLOUGH, Diane L, LINK, Michael P, FOLEY, Kathleen M, CLARRIDGE, Brian C, SCHNIPPER, Lowell E, MAYER, Robert J

“…In 1998, the American Society of Clinical Oncology (ASCO) surveyed its membership to assess the attitudes, practices, and challenges associated with…”
Get full text

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma : a pediatric oncology group study by AMYLON, M. D, SHUSTER, J, KURTZBERG, J, DESAI, S, CAMITTA, B, MURPHY, S, PULLEN, J, BERARD, C, LINK, M. P, WHARAM, M, KATZ, J, YU, A, LAVER, J, RAVINDRANATH, Y

“…This study was designed to test the hypothesis that high-dose asparaginase consolidation therapy improves survival in pediatric patients with T cell acute…”
Get full text

Prognostic Factors for Children With Hodgkin’s Disease Treated With Combined-Modality Therapy by SMITH, Ron S, QING CHEN, HUDSON, Melissa M, LINK, Michael P, KUN, Larry, WEINSTEIN, Howard, BILLETT, Amy, MARCUS, Karen J, TARBELL, Nancy J, DONALDSON, Sarah S

“…Evaluation of pretreatment factors to identify children at high risk for relapse after combined-modality therapy for Hodgkin's disease. From 1990 to 2000, 328…”
Get full text

What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? by Arndt, Carola A. S., Donaldson, Sarah S., Anderson, James R., Andrassy, Richard J., Laurie, Fran, Link, Michael P., Raney, R. Beverly, Maurer, Harold M., Crist, William M.

“…BACKGROUND Factors affecting outcome for rhabdomyosarcoma (RMS) of the female genital tract in patients treated on Intergroup Rhabdomyosarcoma Study Group…”
Get full text

Cancer care during the last phase of life

“…EXECUTIVE SUMMARY: The American Society of Clinical Oncology (ASCO) believes that it is the oncologists' responsibility to care for their patients in a…”
Get more information

High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation for Recurrent or Refractory Pediatric Hodgkin's Disease: Results and Prognostic Indices by LIESKOVSKY, Yeeyie E, DONALDSON, Sarah S, TORRES, Mylin A, WONG, Ruby M, AMYLON, Michael D, LINK, Michael P, AGARWAL, Rajni

“…To evaluate the outcome of pediatric patients with refractory or relapsed Hodgkin's disease (HD) who undergo high-dose therapy and autologous hematopoietic…”
Get full text

Risk-Adapted, Combined-Modality Therapy With VAMP/COP and Response-Based, Involved-Field Radiation for Unfavorable Pediatric Hodgkin's Disease by HUDSON, Melissa M, KRASIN, Matthew, HOWARD, Scott, FRIEDMANN, Alison M, HURWITZ, Craig A, YOUNG, Jeffrey A, MARCUS, Karen C, RAI, Shesh, COWAN, Traci, WEINSTEIN, Howard J, LINK, Michael P, DONALDSON, Sarah S, BILLUPS, Catherine, MERCHANT, Thomas E, KUN, Larry, BILLET, Amy L, KASTE, Sue, TARBELL, Nancy J

“…To evaluate the efficacy of vinblastine, doxorubicin, methotrexate, and prednisone (VAMP) and cyclophosphamide, vincristine, and procarbazine (COP)…”
Get full text

VAMP and Low-Dose, Involved-Field Radiation for Children and Adolescents With Favorable, Early-Stage Hodgkin’s Disease: Results of a Prospective Clinical Trial by DONALDSON, Sarah S, HUDSON, Melissa M, WEINSTEIN, Howard J, LAMBORN, Kathleen R, LINK, Michael P, KUN, Larry, BILLETT, Amy Louise, MARCUS, Karen C, HURWITZ, Craig A, YOUNG, Jeffrey A, TARBELL, Nancy J

“…To evaluate outcome and assess toxicity of children and adolescents with early-stage, favorable Hodgkin's disease treated with vinblastine, doxorubicin,…”
Get full text

Magnetic field exposure and long-term survival among children with leukaemia by FOLIART, D. E, POLLOCK, B. H, MEZEI, G, IRIYE, R, SILVA, J. M, EBI, K. L, KHEIFETS, L, LINK, M. P, KAVET, R

“…We examined the association between magnetic field (MF) exposure and survival among children with acute lymphoblastic leukaemia (ALL) treated at 51 Pediatric…”
Get full text

Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (doxil) in children with solid tumors: A pediatric oncology group study by MARINA, Neyssa M, COCHRANE, Debon, HARNEY, Elaine, ZOMORODI, Katie, BLANEY, Susan, WINICK, Naomi, BERNSTEIN, Mark, LINK, Michael P

“…To determine the maximum tolerated dose and pharmacokinetics of Doxil in children with recurrent or refractory solid tumors. Doxil is pegylated doxorubicin…”
Get full text

Benefit of Intensified Therapy for Patients With Local or Regional Embryonal Rhabdomyosarcoma: Results From the Intergroup Rhabdomyosarcoma Study IV by BAKER, K. S, ANDERSON, J. R, LINK, M. P, GRIER, H. E, QUALMAN, S. J, MAURER, H. M, BRENEMAN, J. C, WIENER, E. S, CRIST, W. M

“…To compare failure-free survival (FFS) and survival for patients with local or regional embryonal rhabdomyosarcoma treated on the Intergroup Rhabdomyosarcoma…”
Get full text

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group by SPUNT, Sheri L, SMITH, Lynette M, RUYMANN, Frederick B, QUALMAN, Stephen J, DONALDSON, Sarah S, RODEBERG, David A, ANDERSON, James R, CRIST, William M, LINK, Michael P

“…More than half of pediatric rhabdomyosarcoma cases have intermediate-risk features and suboptimal outcome (3-year failure-free survival estimates, 55 to 76%)…”
Get full text